SEARCH

SEARCH BY CITATION

References

  • Alexander SPH, Mathie A, Peters JA (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1S254.
  • Antzelevitch C (2004). Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem? J Electrocardiol 37 (Suppl.): 1524.
  • Antzelevitch C, Shimizu M, Yan GX, Sicouri S, Weissenburger J, Nesterenko VV et al. (1999). The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 10: 11241152.
  • Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, Fish JM et al. (2004). Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 110: 904910.
  • Antzelevitch C, Sicouri S, Di Diego JM, Burashnikov A, Viskin S, Shimizu W et al. (2007). Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm 4: 11141116.
  • Carmeliet E (1977). Repolarisation and frequency in cardiac cells. J Physiol (Paris) 73: 903923.
  • Carmeliet E (1987). Slow inactivation of the sodium current in rabbit cardiac Purkinje fibers. Pflugers Arch 408: 1826.
  • Fenichel RR, Malik M, Antzelevitch C, Sanguinetti M, Roden DM, Priori SG et al. (2004). Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol 15: 475495.
  • Guo D, Young LH, Wu Y, Belardinelli L, Kowey PR, Yan GX (2010). Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial arrhythmias. Am J Physiol Heart Circ Physiol 298: H1375H1381.
  • Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT et al. (2008). T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol 41: 567574.
  • Gussak I, Litwin J, Morganroth J (2007). Proarrhythmic potential of reverse use-dependent drugs. J Electrocardiol 40: 432433.
  • Hale SL, Shryock JC, Belardinelli L, Sweeney M, Kloner RA (2008). Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol 44: 954967.
  • Hondeghem LM (2005). TRIad: foundation for proarrhythmia (triangulation, reverse use-dependence and instability). Novartis Found Symp 266: 235244.
  • Joshi A, Dimino T, Vohra Y, Cui C, Yan GX (2004). Preclinical strategies to assess QT liability and torsadogenic potential of new drugs: the role of experimental models. J Electrocardiol 37 Suppl.: 714.
  • Jurkiewicz NK, Sanguinetti MC (1993). Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly active delayed rectifier K+ current by dofetilide. Circ Res 72: 7583.
  • Liu DW, Antzelevitch C (1995). Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial and endocardial myocytes: a weaker IKs contributes to the longer action potential of the M cell. Circ Res 76: 351365.
  • Liu T, Brown BS, Wu Y, Antzelevitch C, Kowey PR, Yan GX (2006). Blinded Validation of the Isolated Arterially Perfused Rabbit Ventricular Wedge in Preclinical Assessment of Drug-Induced Proarrhythmias. Heart Rhythm 3: 948956.
  • Maltsev VA, Undrovinas A (2008). Late sodium current in failing heart: friend or foe? Prog Biophys Molec Biol 96: 421451.
  • Moss AJ, Zareba W, Schwarz KQ, Rosero S, Mcnitt S, Robinson JL (2008). Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol 19: 12891293.
  • Nuyens D, Stengl M, Dugarmaa S, Rossenbacker T, Compernolle V, Rudy Y et al. (2001). Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 7: 10211027.
  • Patel C, Burke JF, Patel H, Gupta P, Kowey PR, Antzelevitch C et al. (2009). Is there a significant transmural gradient in repolarization time in the intact heart? Cellular basis of the T wave: a century of controversy. Circ Arrhythm Electrophysiol 2: 8088.
  • Redfern WS, Carlsson L, Davis AS, Lynch WG, Mackenzie I, Palethorpe S et al. (2003). Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res 58: 3245.
  • Roden DM (2004). Drug-induced prolongation of the QT interval. N Engl J Med 350: 10131022.
  • Salata JJ, Jurkiewicz NK, Wang J, Evans BE, Orme HT, Sanguinetti MC (1998). A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents. Molec Pharmacol 54: 220230.
  • Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM et al. (2007). Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 116: 16471652.
  • Stengl M, Volders PG, Thomsen MB, Spatjens RL, Sipido KR, Vos MA (2003). Accumulation of slowly activating delayed rectifier potassium current (IKs) in canine ventricular myocytes. J Physiol 551: 777786.
  • Undrovinas AI, Maltsev VA, Kyle JW, Silverman N, Sabbah HN (2002). Gating of the late Na+ channel in normal and failing human myocardium. J Mol Cell Cardiol 34: 14771489.
  • Wang D, Patel C, Cui C, Yan GX (2008). Preclinical assessment of drug-induced proarrhythmias: role of the arterially perfused rabbit left ventricular wedge preparation. Pharmacol Ther 119: 141151.
  • Wu L, Shryock JC, Song Y, Belardinelli L (2006). An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts. J Pharmacol Exp Ther 316: 718726.
  • Wu L, Guo D, Li H, Hackett J, Yan GX, Jiao Z et al. (2008). Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine. Heart Rhythm 5: 17261734.
  • Xu X, Rials SJ, Wu Y, Salata JJ, Liu T, Bharucha D et al. (2001). Left ventricular hypertrophy decreases slowly, but not rapidly activating delayed rectifier K+ currents of epicardial and endocardial myocytes in rabbits. Circulation 103: 15851590.
  • Yan GX, Antzelevitch C (1998). Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 98: 19281936.
  • Yan GX, Antzelevitch C (1999). Cellular basis for the Brugada syndrome and other Mechanisms of arrhythmogenesis associated with ST Segment Elevation. Circulation 100: 16601666.
  • Yan GX, Rials SJ, Wu Y, Liu T, Xu X, Marinchak Ra et al. (2001a). Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early afterdepolarization. Am J Physiol 281: H1968H1975.
  • Yan GX, Wu Y, Liu T, Wang J, Marinchak RA, Kowey PR (2001b). Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome:Direct evidence from intracellular recordings in the intact left ventricular wall. Circulation 103: 28512856.
  • Yang T, Roden DM (1996). Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. Circulation 93: 407411.
  • Zygmunt AC, Eddlestone GT, Thomas GP, Nesterenko VV, Antzelevitch C (2001). Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol Heart Circ Physiol 281: H689H697.